Found: 13
Select item for more details and to access through your institution.
Pharmacologic Options for Treatment of Levodopa-Associated "Wearing Off".
- Published in:
- Journal of Pharmacy Practice, 2008, v. 21, n. 4, p. 254, doi. 10.1177/0897190008321846
- By:
- Publication type:
- Article
Targeted sequencing of Parkinson's disease loci genes highlights SYT11, FGF20 and other associations.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Heart Rate and Perceived Exertion Measures During Exercise in People with Parkinson's Disease.
- Published in:
- Neurorehabilitation & Neural Repair, 1996, v. 10, n. 2, p. 101, doi. 10.1177/154596839601000204
- By:
- Publication type:
- Article
Basal ganglia calcification after mumps encephalitis.
- Published in:
- Movement Disorders, 1996, v. 11, n. 6, p. 755, doi. 10.1002/mds.870110631
- By:
- Publication type:
- Article
Side effects of selegiline (Eldepryl).
- Published in:
- 1992
- By:
- Publication type:
- journal article
Cognitive and Motor Function in Long-Duration PARKIN-Associated Parkinson Disease.
- Published in:
- JAMA Neurology, 2014, v. 71, n. 1, p. 62, doi. 10.1001/jamaneurol.2013.4498
- By:
- Publication type:
- Article
The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities.
- Published in:
- European Journal of Haematology, 1995, v. 54, n. 4, p. 245, doi. 10.1111/j.1600-0609.1995.tb00679.x
- By:
- Publication type:
- Article
Elevated GM3 plasma concentration in idiopathic Parkinson’s disease: A lipidomic analysis.
- Published in:
- PLoS ONE, 2017, v. 12, n. 2, p. 1, doi. 10.1371/journal.pone.0172348
- By:
- Publication type:
- Article
Analysis of Heterozygous PRKN Variants and Copy‐Number Variations in Parkinson's Disease.
- Published in:
- Movement Disorders, 2021, v. 36, n. 1, p. 178, doi. 10.1002/mds.28299
- By:
- Publication type:
- Article
Zydis selegiline reduces off time in Parkinson's disease patients with motor fluctuations: A 3-month, randomized, placebo-controlled study.
- Published in:
- Movement Disorders, 2004, v. 19, n. 4, p. 426, doi. 10.1002/mds.20036
- By:
- Publication type:
- Article
Transdermal dopaminergic D<sub>2</sub> receptor agonist therapy in Parkinson's disease with N-0923 TDS: A double-blind, placebo-controlled study.
- Published in:
- Movement Disorders, 2001, v. 16, n. 3, p. 459, doi. 10.1002/mds.1085
- By:
- Publication type:
- Article
A 32-year-old man with progressive spasticity and parkinsonism.
- Published in:
- Movement Disorders, 1999, v. 14, n. 2, p. 350, doi. 10.1002/1531-8257(199903)14:2<350::AID-MDS1024>3.0.CO;2-0
- By:
- Publication type:
- Article
Sexuality in women with parkinson's disease.
- Published in:
- Movement Disorders, 1997, v. 12, n. 6, p. 923, doi. 10.1002/mds.870120614
- By:
- Publication type:
- Article